Evidence map›Paper›PMID 38246952›Full record

ArticlePlant cell reports2024

Multifactorial analysis of terminator performance on heterologous gene expression in Physcomitrella.

Paul Alexander Niederau, Pauline Eglé, Sandro Willig, Juliana Parsons, Sebastian N W Hoernstein, Eva L Decker, Ralf Reski

Open access · hybridAbstract read
In one paragraph

Article in Plant cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Recombinant Protein Drugs: A 2025 Update.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Differential prolyl hydroxylation by six Physcomitrella prolyl-4 hydroxylases.Computational and structural biotechnology journal · 2024
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Paul Alexander NiederauPlant Biotechnology, Faculty of Biology, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0009-0004-0194-8570
Pauline EgléPlant Biotechnology, Faculty of Biology, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0009-0002-1115-5828
Sandro WilligPlant Biotechnology, Faculty of Biology, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0009-0001-2816-4918
Juliana ParsonsPlant Biotechnology, Faculty of Biology, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0001-6261-2342
Sebastian N W HoernsteinPlant Biotechnology, Faculty of Biology, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0002-2095-689X
Eva L DeckerPlant Biotechnology, Faculty of Biology, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0002-9151-1361
Ralf ReskiPlant Biotechnology, Faculty of Biology, University of Freiburg, Freiburg, Germany. ralf.reski@biologie.uni-freiburg.de.ORCID http://orcid.org/0000-0002-5496-6711
University of Freiburg · DE

Funding

Deutsche Forschungsgemeinschaft EXC-2189HORIZON EUROPE Marie Sklodowska-Curie Actions 765115
6 · The paper itself

Abstract

key messageCharacterization of Physcomitrella 3'UTRs across different promoters yields endogenous single and double terminators for usage in molecular pharming. The production of recombinant proteins for health applications accounts for a large share of the biopharmaceutical market. While many drugs are produced in microbial and mammalian systems, plants gain more attention as expression hosts to produce eukaryotic proteins. In particular, the good manufacturing practice (GMP)-compliant moss Physcomitrella (Physcomitrium patens) has outstanding features, such as excellent genetic amenability, reproducible bioreactor cultivation, and humanized protein glycosylation patterns. In this study, we selected and characterized novel terminators for their effects on heterologous gene expression. The Physcomitrella genome contains 53,346 unique 3'UTRs (untranslated regions) of which 7964 transcripts contain at least one intron. Over 91% of 3'UTRs exhibit more than one polyadenylation site, indicating the prevalence of alternative polyadenylation in Physcomitrella. Out of all 3'UTRs, 14 terminator candidates were selected and characterized via transient Dual-Luciferase assays, yielding a collection of endogenous terminators performing equally high as established heterologous terminators CaMV35S, AtHSP90, and NOS. High performing candidates were selected for testing as double terminators which impact reporter levels, dependent on terminator identity and positioning. Testing of 3'UTRs among the different promoters NOS, CaMV35S, and PpActin5 showed an increase of more than 1000-fold between promoters PpActin5 and NOS, whereas terminators increased reporter levels by less than tenfold, demonstrating the stronger effect promoters play as compared to terminators. Among selected terminator attributes, the number of polyadenylation sites as well as polyadenylation signals were found to influence terminator performance the most. Our results improve the biotechnology platform Physcomitrella and further our understanding of how terminators influence gene expression in plants in general.

Indexed as

BryophytaBryopsida3' Untranslated RegionsAnimalsGene ExpressionMammalsMolecular Farming3' Untranslated RegionsMolecular pharmingMossPhyscomitriumPlant biotechnologyUTR

Identifiers

PMID38246952
PMCPMC10800305
OpenAlexW4391076688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.